4.6 Article Proceedings Paper

Primary and secondary prevention of periodontal and peri-implant diseases Introduction to, and objectives of the 11th European Workshop on Periodontology consensus conference

Journal

JOURNAL OF CLINICAL PERIODONTOLOGY
Volume 42, Issue -, Pages S1-S4

Publisher

WILEY
DOI: 10.1111/jcpe.12382

Keywords

clinical recommendations; consensus conference; evidence based medicine; gingival bleeding; gingivitis; health policy; peri-implant mucositis; peri-implantitis; periodontitis; prevention; public health

Funding

  1. Colgate-Palmolive
  2. Procter Gamble
  3. Johnson Johnson
  4. Sunstar
  5. Unilever
  6. Philips
  7. Dentaid
  8. Ivoclar-Vivadent
  9. Heraeus-Kulzer
  10. Straumann
  11. European Federation of Periodontology through Johnson Johnson
  12. European Federation of Periodontology through Procter Gamble

Ask authors/readers for more resources

BackgroundPeriodontitis prevalence remains high. Peri-implantitis is an emerging public health issue. Such a high burden of disease and its social, oral and systemic consequences are compelling reasons for increased attention towards prevention for individuals, professionals and public health officials. MethodsSixteen systematic reviews and meta-reviews formed the basis for workshop discussions. Deliberations resulted in four consensus reports. ResultsThis workshop calls for renewed emphasis on the prevention of periodontitis and peri-implantitis. A critical element is the recognition that prevention needs to be tailored to the individual's needs through diagnosis and risk profiling. Discussions identified critical aspects that may help in the large-scale implementation of preventive programs: (i) a need to communicate to the public the critical importance of gingival bleeding as an early sign of disease, (ii) the need for universal implementation of periodontal screening by the oral health care team, (iii) the role of the oral health team in health promotion and primary and secondary prevention, (iv) understanding the limitations of self-medication with oral health care products without a diagnosis of the underlying condition, and (v) access to appropriate and effective professional preventive care. ConclusionsThe workshop provided specific recommendations for individuals, the oral health team and public health officials. Their implementation in different countries requires adaptation to respective specific national oral health care models.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available